Mr. Speaker, my department has taken action by working with the isotopes experts to develop guidance on dealing with the shortage. We are also using a special access program in the clinical trials to provide alternatives to Canadians.
Many tests can be completed using other options, such as thallium and sodium fluoride. While these are not long-term solutions, they provide doctors with more options to ensure that patients who require testing and who cannot use the alternatives, such as children, can receive TC99.